Last reviewed · How we verify
NCT03852836: BiliFast
Evaluation of MRI Sequences for Ultra-rapid Acquisition of Bile Ducts Images
NA trial testing ultra-rapid acquisition of bile ducts images in Gallstone in 53 participants. Terminated before completion.
15 September 2021
Quick facts
| Lead sponsor | IHU Strasbourg |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 53 |
| Start date | 26 February 2019 |
| Primary completion | 15 September 2021 |
| Estimated completion | 15 September 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- ultra-rapid acquisition of bile ducts images
Conditions studied
- Gallstone — all drugs for Gallstone →
- Cholangitis — all drugs for Cholangitis →
- Cholangiocarcinoma — all drugs for Cholangiocarcinoma →
- Pancreatitis — all drugs for Pancreatitis →
Sponsor
IHU Strasbourg — full company profile →
Who can join
18 and older, any sex, with Gallstone or Cholangitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Institute of Imaged-Guided Surgery (IHU Strasbourg) has two clinical Magnetic Resonance Imaging (MRI) scanners, one with a 3T (3 Teslas) magnetic field used for diagnosis, the other with a magnetic field of 1,5T (1,5 Teslas) used for the interventional (Pre / per / postoperative). The reference for the visualization of the biliary and pancreatic ducts is a relatively long sequence that needs a breathing-synchronized acquisition leading to artefacts on the images (blur effect). In order to reduce and/or standardize the acquisition time as well as to limit artefacts, accelerated sequences are developed. Such sequence is available in France recently in the form of WIP Siemens (Work In Progress: sequence in test phase at manufacturer to be marketed in the short or medium term on clinical machines). It incorporates a Compressed Sensing (CS) acquisition scheme allowing the acquisition of a 3D (3 dimensions) sequence similar to the usual sequence by drastically reducing the acquisition time, the sequence CS-SPACE. This sequence exists in two forms: * An ultra-rapid sequence acquired in apnea * An accelerated sequence but remaining synchronized with the breath. The study carried out here on a large number of patients, with two different magnetic fields, applied routinely for diagnosis or anticipation of surgery, could be used by the community of radiologists, hepatogastroenterologists and also digestive surgeons Hepatobiliary.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03852836
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Gallstone
Currently open trials in the same condition.
- NCT03326154 — Post-Cholecystectomy Quality of Life · recruiting
Other IHU Strasbourg trials
Trials by the same sponsor.
- NCT06017427 — Evaluation of Patient Satisfaction During Treatment With Dupilumab in Severe and Recurrent Nasosinusal Polyposis Despite · terminated
- NCT05515705 — First-in-human Navigation Endoscopic Ultrasound (EUS) System Clinical Study · NA · terminated
- NCT05357729 — Safety and Performance Study of the MultiSense® Ambulatory Telemonitoring System for Non-critical Patient Management · NA · completed
- NCT04899739 — Intraoperative Endoscopic Ultrasound for Pancreatic Cancer · NA · completed
- NCT05044585 — Evaluation of RDS MultiSense® in Desaturation Analysis in Healthy Volunteers · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03852836 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by IHU Strasbourg
- Last refreshed: 6 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03852836.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing